These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9568099)

  • 41. Dietary fish oil decreases secretion of T helper (Th) 1-type cytokines by a direct effect on murine splenic T cells but enhances secretion of a Th2-type cytokine by an effect on accessory cells.
    Petursdottir DH; Hardardottir I
    Br J Nutr; 2009 Apr; 101(7):1040-6. PubMed ID: 18680632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function.
    Sharma S; Stolina M; Lin Y; Gardner B; Miller PW; Kronenberg M; Dubinett SM
    J Immunol; 1999 Nov; 163(9):5020-8. PubMed ID: 10528207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective pharmacologic inhibition of murine and human IL-12-dependent Th1 differentiation and IL-12 signaling.
    Coon ME; Diegel M; Leshinsky N; Klaus SJ
    J Immunol; 1999 Dec; 163(12):6567-74. PubMed ID: 10586050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 or interleukin-4 in nude mice: a potentiality for cancer gene therapy.
    Kimura M; Tagawa M; Takenaga K; Kondo F; Yamaguchi T; Saisho H; Nakagawara A; Sakiyama S
    Cancer Lett; 1998 Jun; 128(1):47-53. PubMed ID: 9652792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acquired immunity in nude mice induced by expression of the IL-2 or IL-4 gene in human pancreatic carcinoma cells and anti-tumor effect generated by in vivo gene transfer using retrovirus.
    Kimura M; Yoshida Y; Narita M; Takenaga K; Takenouchi T; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
    Int J Cancer; 1999 Aug; 82(4):549-55. PubMed ID: 10404069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired tumorigenicity of IL-4-producing murine neuroblastoma cells in immunodeficient nude mice.
    Yoshida H; Enomoto H; Miyauchi M; Takenaga K; Tanabe M; Ohnuma N; Sakiyama S; Tagawa M
    Int J Oncol; 1998 May; 12(5):1067-71. PubMed ID: 9538130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antitumor response of genetically engineered IL-2 expression to human esophageal carcinoma cells in mature T cell-defective condition.
    Matsubara H; Koide Y; Sugaya M; Gunji Y; Asano T; Ochiai T; Takegana K; Sakiyama S; Tagawa M
    Int J Oncol; 1998 Dec; 13(6):1217-22. PubMed ID: 9824634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: a possible event in tumor regression.
    Saito K; Ishikura H; Kishimoto T; Kawarada Y; Yano T; Takahashi T; Kato H; Yoshiki T
    Int J Cancer; 1998 Jan; 75(2):284-9. PubMed ID: 9462720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The antiangiogenesis effect of interleukin 12 during early growth of human pancreatic cancer in SCID mice.
    Sunamura M; Sun L; Lozonschi L; Duda DG; Kodama T; Matsumoto G; Shimamura H; Takeda K; Kobari M; Hamada H; Matsuno S
    Pancreas; 2000 Apr; 20(3):227-33. PubMed ID: 10766447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination effect of interleukin-6-producing pancreatic cancer cells in nude mice: a model of tumor prevention and treatment in immune-compromised patients.
    Yano T; Ishikura H; Kato H; Ogawa Y; Kondo S; Kato H; Yoshiki T
    Jpn J Cancer Res; 2001 Jan; 92(1):83-7. PubMed ID: 11173548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Down-regulation of Th1 responses in human neonates.
    Marodi L
    Clin Exp Immunol; 2002 Apr; 128(1):1-2. PubMed ID: 11982583
    [No Abstract]   [Full Text] [Related]  

  • 52. The role of IL12 in helper T-cell differentiation.
    Perez VL; Lederer JA; Carniel E; Lichtman A; Abbas AK
    Res Immunol; 1995; 146(7-8):477-80. PubMed ID: 8839149
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of interleukin-12 in human Th1 response.
    Trinchieri G
    Chem Immunol; 1996; 63():14-29. PubMed ID: 8934829
    [No Abstract]   [Full Text] [Related]  

  • 54. Interleukin 18: tipping the balance towards a T helper cell 1 response.
    Swain SL
    J Exp Med; 2001 Aug; 194(3):F11-4. PubMed ID: 11489958
    [No Abstract]   [Full Text] [Related]  

  • 55. Interleukin-12 and up: functions of T helper subsets resulting from differential cytokine production.
    O'Garra A
    Res Immunol; 1997; 148(6):413-6. PubMed ID: 9443580
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of endogenous IL12 in the induction of Th1-cell-mediated autoimmune diseases.
    Adorini L; Magram J; Trembeau S
    Res Immunol; 1995; 146(7-8):645-51. PubMed ID: 8839173
    [No Abstract]   [Full Text] [Related]  

  • 57. Minimal requirements for characterization of cytokine gene-transduced tumor cells: a proposal.
    Lollini PL; Nanni P
    J Natl Cancer Inst; 1995 Nov; 87(22):1717-8. PubMed ID: 7473823
    [No Abstract]   [Full Text] [Related]  

  • 58. [Interleukin-12--polyfunctional cytokine].
    Aharon-Maor A; Shoenfeld Y
    Harefuah; 1996 Dec; 131(11):501-5. PubMed ID: 9043164
    [No Abstract]   [Full Text] [Related]  

  • 59. Oncolytic Virus-Based Cytokine Expression to Improve Immune Activity in Brain and Solid Tumors.
    Pearl TM; Markert JM; Cassady KA; Ghonime MG
    Mol Ther Oncolytics; 2019 Jun; 13():14-21. PubMed ID: 30997392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells.
    Dai S; Zhou X; Wang B; Wang Q; Fu Y; Chen T; Wan T; Yu Y; Cao X
    J Mol Med (Berl); 2006 Dec; 84(12):1067-76. PubMed ID: 17016692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.